Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

173 structures for P15121

Entry ID Method Resolution Chain Position Source
1ABN X-ray 240 A A 2-316 PDB
1ADS X-ray 165 A A 2-316 PDB
1AZ1 X-ray 180 A A 2-316 PDB
1AZ2 X-ray 290 A A 2-316 PDB
1EF3 X-ray 280 A A/B 2-316 PDB
1EL3 X-ray 170 A A 1-316 PDB
1IEI X-ray 250 A A 1-316 PDB
1MAR X-ray 180 A A 2-316 PDB
1PWL X-ray 110 A A 1-316 PDB
1PWM X-ray 092 A A 1-316 PDB
1T40 X-ray 180 A A 1-316 PDB
1T41 X-ray 105 A A 1-316 PDB
1US0 X-ray 066 A A 1-316 PDB
1X96 X-ray 140 A A 1-316 PDB
1X97 X-ray 140 A A 1-316 PDB
1X98 X-ray 130 A A 1-316 PDB
1XGD X-ray 210 A A 2-316 PDB
1Z3N X-ray 104 A A 1-316 PDB
1Z89 X-ray 143 A A 1-316 PDB
1Z8A X-ray 095 A A 1-316 PDB
2ACQ X-ray 176 A A 2-316 PDB
2ACR X-ray 176 A A 2-316 PDB
2ACS X-ray 176 A A 2-316 PDB
2ACU X-ray 176 A A 2-316 PDB
2AGT X-ray 100 A A 1-316 PDB
2DUX X-ray 160 A A 1-316 PDB
2DUZ X-ray 160 A A 1-316 PDB
2DV0 X-ray 162 A A 1-316 PDB
2F2K X-ray 194 A A 1-316 PDB
2FZ8 X-ray 148 A A 1-316 PDB
2FZ9 X-ray 160 A A 1-316 PDB
2FZB X-ray 150 A A 6-316 PDB
2FZD X-ray 108 A A 6-316 PDB
2HV5 X-ray 159 A A 1-316 PDB
2HVN X-ray 158 A A 1-316 PDB
2HVO X-ray 165 A A 1-316 PDB
2I16 X-ray 081 A A 1-316 PDB
2I17 X-ray 081 A A 1-316 PDB
2IKG X-ray 143 A A 1-316 PDB
2IKH X-ray 155 A A 1-316 PDB
2IKI X-ray 147 A A 1-316 PDB
2IKJ X-ray 155 A A 1-316 PDB
2INE X-ray 190 A A 2-316 PDB
2INZ X-ray 195 A A 2-316 PDB
2IPW X-ray 200 A A 2-316 PDB
2IQ0 X-ray 195 A A 2-316 PDB
2IQD X-ray 200 A A 2-316 PDB
2IS7 X-ray 170 A A 2-316 PDB
2ISF X-ray 200 A A 2-316 PDB
2J8T X-ray 082 A A 6-316 PDB
2NVC X-ray 165 A A 1-316 PDB
2NVD X-ray 155 A A 1-316 PDB
2PD5 X-ray 160 A A 1-316 PDB
2PD9 X-ray 155 A A 1-316 PDB
2PDB X-ray 160 A A 1-316 PDB
2PDC X-ray 165 A A 1-316 PDB
2PDF X-ray 156 A A 1-316 PDB
2PDG X-ray 142 A A 1-316 PDB
2PDH X-ray 145 A A 1-316 PDB
2PDI X-ray 155 A A 1-316 PDB
2PDJ X-ray 157 A A 1-316 PDB
2PDK X-ray 155 A A 1-316 PDB
2PDL X-ray 147 A A 1-316 PDB
2PDM X-ray 175 A A 1-316 PDB
2PDN X-ray 170 A A 1-316 PDB
2PDP X-ray 165 A A 1-316 PDB
2PDQ X-ray 173 A A 1-316 PDB
2PDU X-ray 155 A A 1-316 PDB
2PDW X-ray 155 A A 1-316 PDB
2PDX X-ray 165 A A 1-316 PDB
2PDY X-ray 165 A A 1-316 PDB
2PEV X-ray 090 A A 1-316 PDB
2PF8 X-ray 085 A A 1-316 PDB
2PFH X-ray 085 A A 1-316 PDB
2PZN X-ray 100 A A 1-316 PDB
2QXW X-ray 080 A A 1-316 PDB
2R24 X-ray 175 A A 1-316 PDB
3BCJ X-ray 078 A A 1-316 PDB
3DN5 X-ray 145 A A 1-316 PDB
3G5E X-ray 180 A A 1-316 PDB
3GHR X-ray 100 A A 1-316 PDB
3GHS X-ray 100 A A 1-316 PDB
3GHT X-ray 110 A A 1-316 PDB
3GHU X-ray 120 A A 1-316 PDB
3LBO X-ray 110 A A 1-316 PDB
3LD5 X-ray 127 A A 1-316 PDB
3LEN X-ray 121 A A 1-316 PDB
3LEP X-ray 099 A A 1-316 PDB
3LQG X-ray 135 A A 1-316 PDB
3LQL X-ray 113 A A 1-316 PDB
3LZ3 X-ray 103 A A 1-316 PDB
3LZ5 X-ray 095 A A 1-316 PDB
3M0I X-ray 107 A A 1-316 PDB
3M4H X-ray 094 A A 1-316 PDB
3M64 X-ray 130 A A 1-316 PDB
3MB9 X-ray 165 A A 1-316 PDB
3MC5 X-ray 114 A A 1-316 PDB
3ONB X-ray 145 A A 2-316 PDB
3ONC X-ray 106 A A 2-316 PDB
3P2V X-ray 169 A A 1-316 PDB
3Q65 X-ray 209 A A/B 1-316 PDB
3Q67 X-ray 155 A A/B 1-316 PDB
3RX2 X-ray 190 A A 1-316 PDB
3RX3 X-ray 190 A A 1-316 PDB
3RX4 X-ray 200 A A 1-316 PDB
3S3G X-ray 180 A A 1-316 PDB
3T42 X-ray 128 A A 1-316 PDB
3U2C X-ray 100 A A 1-316 PDB
3V35 X-ray 190 A A 1-316 PDB
3V36 X-ray 200 A A 1-316 PDB
4GCA X-ray 090 A A 2-316 PDB
4GQ0 X-ray 210 A A 1-316 PDB
4IGS X-ray 085 A A 1-316 PDB
4JIR X-ray 200 A A 1-316 PDB
4LAU X-ray 084 A A 1-316 PDB
4LAZ X-ray 085 A A 1-316 PDB
4LB3 X-ray 080 A A 1-316 PDB
4LB4 X-ray 080 A A 1-316 PDB
4LBR X-ray 080 A A 1-316 PDB
4LBS X-ray 076 A A 1-316 PDB
4NKC X-ray 112 A A 2-316 PDB
4PR4 X-ray 106 A A 2-316 PDB
4PRR X-ray 101 A A 2-316 PDB
4PRT X-ray 096 A A 1-316 PDB
4PUU X-ray 114 A A 1-316 PDB
4PUW X-ray 112 A A 1-316 PDB
4Q7B X-ray 119 A A 2-316 PDB
4QBX X-ray 098 A A 1-316 PDB
4QR6 X-ray 105 A A 1-316 PDB
4QX4 X-ray 126 A A 1-316 PDB
4QXI X-ray 087 A A 1-316 PDB
4RPQ X-ray 120 A A 2-316 PDB
4XZH X-ray 100 A A/B 1-316 PDB
4XZI X-ray 245 A A 1-316 PDB
4YS1 X-ray 107 A A 1-316 PDB
4YU1 X-ray 102 A A 1-316 PDB
5HA7 X-ray 165 A A/B 1-316 PDB
5OU0 X-ray 094 A A 1-316 PDB
5OUJ X-ray 096 A A 1-316 PDB
5OUK X-ray 096 A A 1-316 PDB
6F7R X-ray 092 A A 1-316 PDB
6F81 X-ray 097 A A 1-316 PDB
6F82 X-ray 103 A A 1-316 PDB
6F84 X-ray 109 A A 1-316 PDB
6F8O X-ray 117 A A 1-316 PDB
6SYW X-ray 093 A A 1-316 PDB
6T27 X-ray 111 A A 1-316 PDB
6T3P X-ray 097 A A 1-316 PDB
6T5G X-ray 128 A A 1-316 PDB
6T7Q X-ray 101 A A 1-316 PDB
6TD8 X-ray 097 A A 1-316 PDB
6TUC X-ray 106 A A 1-316 PDB
6TUF X-ray 115 A A 1-316 PDB
6TXP X-ray 095 A A 1-316 PDB
6XUM X-ray 097 A A 1-316 PDB
6Y03 X-ray 169 A A 1-316 PDB
6Y1P X-ray 094 A A 1-316 PDB
8A4N X-ray 093 A A 1-316 PDB
8AE9 X-ray 095 A A 1-316 PDB
8AQG X-ray 095 A A 1-313 PDB
8AQP X-ray 096 A A 1-316 PDB
8AUU X-ray 095 A A 1-316 PDB
8B34 X-ray 097 A A 1-316 PDB
8B3N X-ray 103 A A 1-316 PDB
8B3R X-ray 096 A A 1-316 PDB
8B66 X-ray 095 A A 1-316 PDB
8BJL X-ray 097 A A 1-316 PDB
8FH5 X-ray 162 A A 2-316 PDB
8FH6 X-ray 195 A A 1-316 PDB
8FH7 X-ray 145 A A 1-316 PDB
8FH8 X-ray 160 A A 1-316 PDB
8FH9 X-ray 170 A A 1-316 PDB
AF-P15121-F1 Predicted AlphaFoldDB

252 variants for P15121

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1227903553 1 M>? Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA369321969
rs776171717
2 A>E No ClinGen
ExAC
TOPMed
gnomAD
rs749387574
CA167003447
2 A>T No ClinGen
Ensembl
CA4493610
rs776171717
2 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA4493609
rs770560951
3 S>G No ClinGen
ExAC
gnomAD
TCGA novel 3 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA369321961
rs772775959
4 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA167003436
rs772775959
4 R>G No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 4 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4493607
rs772775959
4 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA4493606
rs772045888
5 L>F No ClinGen
ExAC
gnomAD
rs1286167481
CA369321955
5 L>H No ClinGen
gnomAD
rs1019342899
CA167003430
6 L>Q No ClinGen
Ensembl
rs754789251
CA4493603
9 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs577826776
CA4493602
10 G>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1379579977
CA369321926
10 G>R No ClinGen
gnomAD
CA369321927
rs1379579977
10 G>S No ClinGen
gnomAD
rs757493252
CA4493600
11 A>G No ClinGen
ExAC
gnomAD
CA4493599
rs751652725
12 K>E No ClinGen
ExAC
gnomAD
CA369321902
CA369321904
rs1490571862
13 M>I No ClinGen
gnomAD
rs1294495813
CA369321896
14 P>L No ClinGen
gnomAD
rs5054
CA167003421
VAR_014743
15 I>F No ClinGen
UniProt
TOPMed
dbSNP
gnomAD
rs759016088
CA4493597
15 I>N No ClinGen
ExAC
gnomAD
rs5054
CA369321894
15 I>V No ClinGen
TOPMed
gnomAD
CA369321881
rs1392886142
17 G>A No ClinGen
TOPMed
CA4493596
rs143744154
18 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 19 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs759994468
CA4493594
20 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA369321866
rs759994468
20 T>S No ClinGen
ExAC
TOPMed
gnomAD
CA369321050
rs1292342051
24 P>L No ClinGen
TOPMed
gnomAD
rs1376636728
CA369321039
26 G>E No ClinGen
gnomAD
rs1462112449
CA369321035
27 Q>* No ClinGen
TOPMed
rs773845040
CA4493570
27 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA4493569
rs555243165
28 V>L No ClinGen
1000Genomes
ExAC
gnomAD
CA369321024
rs1408411023
29 T>A No ClinGen
gnomAD
rs371350653
CA4493568
29 T>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs764315032
CA4493564
32 V>M No ClinGen
ExAC
gnomAD
CA369320979
rs1422453741
36 I>V No ClinGen
gnomAD
rs748304576
CA4493562
38 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs754399252
CA4493559
39 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA4493560
rs201718247
39 G>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1585715092
CA369320951
40 Y>S No ClinGen
Ensembl
rs200105058
CA4493558
41 R>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA369320946
rs1229108905
41 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA167001198
rs5056
VAR_014744
42 H>L No ClinGen
UniProt
Ensembl
dbSNP
rs1314041501
CA369320941
42 H>Y No ClinGen
TOPMed
gnomAD
CA167001192
rs996513111
43 I>V No ClinGen
TOPMed
rs1485185263
CA369320927
44 D>A No ClinGen
TOPMed
CA369320929
rs1329437875
44 D>N No ClinGen
gnomAD
CA369320913
rs1185528972
46 A>T No ClinGen
TOPMed
rs1390867326
CA369320909
46 A>V No ClinGen
gnomAD
CA369320903
rs1397237724
47 H>P No ClinGen
gnomAD
CA167001187
rs892828323
47 H>Q No ClinGen
Ensembl
TCGA novel 48 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA369320875
rs1429030704
51 N>S No ClinGen
TOPMed
rs1370806069
CA369320858
53 N>K No ClinGen
TOPMed
rs751115722
CA4493553
53 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA167001172
rs934410375
54 E>D No ClinGen
Ensembl
rs553878004
CA4493552
56 G>A No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 56 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA369320835
rs1436218117
57 V>A No ClinGen
TOPMed
CA167001166
rs903328570
57 V>L No ClinGen
Ensembl
rs775523523
CA4493549
58 A>S No ClinGen
ExAC
gnomAD
rs1464196240
CA369320827
59 I>V No ClinGen
Ensembl
TCGA novel 61 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs769563589
CA4493548
61 E>K No ClinGen
ExAC
gnomAD
CA369320813
rs769563589
61 E>Q No ClinGen
ExAC
gnomAD
rs903237372
CA167001156
64 R>G No ClinGen
TOPMed
gnomAD
rs1436755087
CA369320783
65 E>G No ClinGen
gnomAD
CA369320774
rs1376445662
66 Q>R No ClinGen
TOPMed
rs772483114
CA4493545
67 V>A No ClinGen
ExAC
gnomAD
CA4493546
rs776564021
67 V>M No ClinGen
ExAC
gnomAD
rs768801970
CA4493542
69 K>* No ClinGen
ExAC
rs749268678
CA369320755
CA4493541
69 K>N No ClinGen
ExAC
TOPMed
gnomAD
CA369320757
rs1246402712
69 K>R No ClinGen
TOPMed
gnomAD
rs780615158
CA4493540
COSM238747
70 R>C Variant assessed as Somatic; 0.0 impact. prostate [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4493539
rs756570400
70 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA369320751
rs756570400
70 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs781510920
CA4493537
72 E>A No ClinGen
ExAC
TOPMed
gnomAD
rs11544686
CA167001126
72 E>D No ClinGen
TOPMed
CA4493538
rs781510920
72 E>G No ClinGen
ExAC
TOPMed
gnomAD
rs5057
VAR_014745
CA167001124
73 L>V No ClinGen
UniProt
Ensembl
dbSNP
CA4493535
rs751246702
76 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA4493491
rs754547262
82 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA369320658
rs754547262
82 T>R No ClinGen
ExAC
TOPMed
gnomAD
CA167000819
rs1036613744
83 Y>N No ClinGen
Ensembl
CA4493489
rs780206909
84 H>R No ClinGen
ExAC
gnomAD
CA4493488
VAR_048213
rs2229542
90 K>E No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs890428946
CA167000810
91 G>R No ClinGen
Ensembl
CA369320587
rs1341776306
93 C>F No ClinGen
TOPMed
rs767183202
CA4493486
94 Q>* No ClinGen
ExAC
TOPMed
gnomAD
CA167000800
rs932031834
95 K>N No ClinGen
gnomAD
rs148084524
CA4493485
97 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs143736441
CA167000789
98 S>G No ClinGen
ESP
TOPMed
rs116793843
CA369320554
98 S>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA4493482
rs765362829
99 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA4493481
rs374068972
100 L>M No ClinGen
ESP
ExAC
gnomAD
rs761065461
CA4493479
101 K>E No ClinGen
ExAC
gnomAD
CA167000777
rs755435675
102 L>R No ClinGen
Ensembl
rs115638419
CA4493477
103 D>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1470382501
CA369320502
107 L>I No ClinGen
TOPMed
gnomAD
rs200955767
CA167000768
108 Y>C No ClinGen
1000Genomes
rs754080850
CA4493475
109 L>F No ClinGen
ExAC
TOPMed
gnomAD
CA167000763
rs754080850
109 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA369320475
rs1161442982
110 I>T No ClinGen
gnomAD
rs768419303
CA4493473
COSM69608
113 P>L ovary Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1395921638
CA369320428
115 G>S No ClinGen
TOPMed
CA369319930
rs1341068342
118 P>S No ClinGen
TOPMed
CA4493452
rs145091628
120 K>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs267601301
CA167000430
124 P>L No ClinGen
Ensembl
rs1403878780
CA369319863
124 P>S No ClinGen
gnomAD
CA4493451
rs371173126
128 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 129 G>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs146644885
CA4493449
129 G>S No ClinGen
ESP
ExAC
gnomAD
rs373907248
CA369319793
130 N>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs373907248
CA4493448
130 N>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1047476538
CA167000418
132 V>A No ClinGen
TOPMed
CA369319765
rs746868477
133 P>H No ClinGen
ExAC
TOPMed
gnomAD
rs746868477
CA4493447
133 P>L No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 134 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4493446
rs777521530
137 N>D No ClinGen
ExAC
gnomAD
TCGA novel 139 L>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs755234075
CA369319680
140 D>E No ClinGen
ExAC
gnomAD
CA4493443
rs766541770
141 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs754091936
CA4493444
141 T>S No ClinGen
ExAC
gnomAD
TCGA novel 142 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs17856148
CA167000400
142 W>R No ClinGen
Ensembl
rs567860325
CA167000397
143 A>T No ClinGen
1000Genomes
CA4493441
rs750511168
143 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA369319556
rs1361125949
144 A>T No ClinGen
Ensembl
CA369319547
CA4493414
rs770505903
145 M>L No ClinGen
ExAC
TOPMed
gnomAD
CA4493413
rs770505903
145 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA4493412
rs760130465
147 E>K No ClinGen
ExAC
gnomAD
CA369319495
rs1170869525
149 V>L No ClinGen
gnomAD
rs773147883
CA4493411
150 D>V No ClinGen
ExAC
TOPMed
gnomAD
rs771990751
CA4493410
151 E>K No ClinGen
ExAC
gnomAD
rs1023543431
CA166999960
152 G>R No ClinGen
TOPMed
gnomAD
rs1312968929
CA369319440
154 V>L No ClinGen
gnomAD
rs1270285190
CA369319416
156 A>S No ClinGen
TOPMed
rs747992861
CA4493409
156 A>V No ClinGen
ExAC
gnomAD
CA4493408
rs778745784
158 G>V No ClinGen
ExAC
TOPMed
gnomAD
rs1480104657
CA369319370
160 S>Y No ClinGen
gnomAD
CA166999946
rs367750648
164 H>R No ClinGen
ESP
TOPMed
rs1419904939
CA369319271
168 E>D No ClinGen
TOPMed
rs1207008888
CA369319266
169 M>T No ClinGen
gnomAD
CA166999938
rs1003776570
171 L>S No ClinGen
Ensembl
rs11544687
CA166999929
174 P>L No ClinGen
Ensembl
CA166999934
rs905427503
174 P>S No ClinGen
gnomAD
CA166999931
rs905427503
174 P>T No ClinGen
gnomAD
CA4493402
rs757422740
175 G>D No ClinGen
ExAC
TOPMed
gnomAD
CA369319207
rs1310289314
178 Y>H No ClinGen
gnomAD
CA4493399
rs758962979
179 K>E No ClinGen
ExAC
gnomAD
CA369319181
rs1164777704
182 V>I No ClinGen
TOPMed
gnomAD
TCGA novel
rs765608056
CA4493397
183 N>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
ExAC
TOPMed
gnomAD
rs1402962430
CA369319165
184 Q>P No ClinGen
TOPMed
rs1470875799
CA369319133
187 C>S No ClinGen
TOPMed
rs944534411
CA166999738
188 H>N No ClinGen
Ensembl
rs755384865
CA4493376
189 P>Q No ClinGen
ExAC
gnomAD
CA369319077
rs1562907046
195 K>E No ClinGen
Ensembl
CA4493372
rs755740371
200 C>F No ClinGen
ExAC
gnomAD
rs767044900
CA4493370
201 Q>H No ClinGen
ExAC
TOPMed
gnomAD
rs749975265
CA4493371
201 Q>R No ClinGen
ExAC
TOPMed
gnomAD
rs946646731
CA166999721
202 S>C No ClinGen
gnomAD
CA369319018
rs1585710996
203 K>R No ClinGen
Ensembl
VAR_014746
rs5061
CA166999719
204 G>S No ClinGen
UniProt
Ensembl
dbSNP
CA4493368
rs201899655
206 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs763868392
CA4493367
207 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA4493365
rs775137066
209 A>T No ClinGen
ExAC
gnomAD
rs1325010981
CA369318982
209 A>V No ClinGen
gnomAD
rs756616387
CA4493364
210 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA166999700
rs746316716
211 S>G No ClinGen
Ensembl
rs1321971782
CA369318953
214 G>C No ClinGen
TOPMed
gnomAD
rs1321971782
CA369318955
214 G>S No ClinGen
TOPMed
gnomAD
rs1467939858
CA369318947
215 S>A No ClinGen
gnomAD
rs1428133282
CA369318942
216 P>A No ClinGen
gnomAD
CA369318929
rs1181863874
218 R>G No ClinGen
TOPMed
rs772301030
CA4493361
219 P>S No ClinGen
ExAC
gnomAD
CA4493360
rs748119899
220 W>S No ClinGen
ExAC
TOPMed
gnomAD
rs1449861244
CA369318896
221 A>S No ClinGen
gnomAD
rs1449861244
CA369318898
221 A>T No ClinGen
gnomAD
CA369318881
rs1327710888
223 P>H No ClinGen
gnomAD
TCGA novel 223 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs757886145
CA4493330
224 E>G No ClinGen
ExAC
TOPMed
gnomAD
CA4493331
rs777117648
224 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs1585710433
CA369318869
225 D>A No ClinGen
Ensembl
CA4493329
rs752703695
225 D>E No ClinGen
ExAC
gnomAD
rs765212760
CA4493328
226 P>A No ClinGen
ExAC
gnomAD
rs200903070
CA4493327
226 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1232540536
CA369318856
227 S>F No ClinGen
gnomAD
CA369318861
rs1468838236
227 S>P No ClinGen
gnomAD
rs151130700
CA166999552
228 L>H No ClinGen
ESP
TOPMed
rs151130700
CA369318853
228 L>P No ClinGen
ESP
TOPMed
CA4493326
rs753684976
228 L>V No ClinGen
ExAC
gnomAD
rs1484242051
CA369318845
230 E>Q No ClinGen
gnomAD
CA369318838
rs1222473564
231 D>N No ClinGen
gnomAD
rs199858307
CA4493323
236 A>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA166999540
rs762963189
237 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs768636967
CA4493321
237 I>V No ClinGen
ExAC
gnomAD
CA4493319
rs770279911
238 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA4493318
rs770279911
COSM204342
238 A>T Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4493317
rs746287907
239 A>P No ClinGen
ExAC
gnomAD
CA4493315
rs753491056
241 H>R No ClinGen
ExAC
TOPMed
gnomAD
rs1378323150
CA369318764
242 N>S No ClinGen
TOPMed
rs1585710275
CA369318756
243 K>R No ClinGen
Ensembl
CA4493314
rs368616250
244 T>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA369318742
rs1399057016
245 T>I No ClinGen
gnomAD
CA369318738
rs1562906624
246 A>G No ClinGen
Ensembl
rs1407261115
CA369318741
246 A>T No ClinGen
gnomAD
TCGA novel 248 V>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA369318702
rs1585709662
250 I>N No ClinGen
Ensembl
CA4493284
rs145261078
251 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4493285
rs752815623
251 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs759564198
CA4493283
254 M>T No ClinGen
ExAC
gnomAD
rs777017519
CA4493282
255 Q>* No ClinGen
ExAC
gnomAD
CA4493281
rs766847306
256 R>G No ClinGen
ExAC
gnomAD
rs139647493
CA4493280
256 R>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA4493279
rs773615800
258 L>F No ClinGen
ExAC
gnomAD
CA369318643
rs1257585858
259 V>G No ClinGen
gnomAD
rs1483371908
CA369318646
259 V>L No ClinGen
TOPMed
gnomAD
rs201921941
CA4493278
263 K>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4493277
rs147442012
268 E>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA369318583
rs1230446062
269 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
COSM204341
CA369318581
rs1380748552
269 R>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
TCGA novel 272 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs748760893
CA4493274
274 F>L No ClinGen
ExAC
TOPMed
gnomAD
rs1472056924
CA369318238
276 V>A No ClinGen
gnomAD
rs768419190
CA4493252
278 D>H No ClinGen
ExAC
gnomAD
CA4493251
rs762426984
279 F>I No ClinGen
ExAC
gnomAD
rs995091941
CA369318155
283 S>R No ClinGen
gnomAD
rs755585273
CA166998612
284 Q>H No ClinGen
TOPMed
gnomAD
CA4493249
rs750121058
285 D>N No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 286 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
VAR_014747
rs5062
CA4493248
288 T>I No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs770727307
CA4493245
292 Y>H No ClinGen
ExAC
gnomAD
CA4493244
rs201721722
296 W>C No ClinGen
1000Genomes
ExAC
gnomAD
CA4493243
rs779176563
299 C>S No ClinGen
ExAC
gnomAD
rs755184764
CA369318033
300 A>G No ClinGen
ExAC
gnomAD
rs755184764
CA4493242
300 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs749559219
CA4493218
304 C>S No ClinGen
ExAC
TOPMed
gnomAD
rs1348439607
CA369317991
305 T>A No ClinGen
TOPMed
CA369317990
rs1348439607
305 T>P No ClinGen
TOPMed
rs1040268676
CA166997772
308 K>M No ClinGen
Ensembl
CA369317946
rs1442026734
311 P>S No ClinGen
gnomAD
CA4493215
rs781778959
313 H>L No ClinGen
ExAC
gnomAD
CA369317931
rs781778959
313 H>P No ClinGen
ExAC
gnomAD
CA4493214
rs781778959
313 H>R No ClinGen
ExAC
gnomAD
CA4493213
rs757815855
314 E>D No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 315 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1274552433
CA369317917
315 E>G No ClinGen
gnomAD
CA166997758
rs764619605
316 F>C No ClinGen
gnomAD
CA4493212
rs752010122
316 F>I No ClinGen
ExAC
gnomAD
CA4493211
rs764583222
317 F>R No ClinGen
ExAC
gnomAD

No associated diseases with P15121

4 regional properties for P15121

Type Name Position InterPro Accession
conserved_site Aldo/keto reductase, conserved site 39 - 56 IPR018170-1
conserved_site Aldo/keto reductase, conserved site 145 - 162 IPR018170-2
conserved_site Aldo/keto reductase, conserved site 261 - 276 IPR018170-3
domain NADP-dependent oxidoreductase domain 16 - 289 IPR023210

Functions

Description
EC Number 1.1.1.21 With NAD(+) or NADP(+) as acceptor
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.

8 GO annotations of molecular function

Name Definition
alditol:NADP+ 1-oxidoreductase activity Catalysis of the reaction: an alditol + NADP+ = an aldose + NADPH + H+.
allyl-alcohol dehydrogenase activity Catalysis of the reaction: allyl alcohol + NADP(+) = acrolein + H(+) + NADPH.
electron transfer activity Any molecular entity that serves as an electron acceptor and electron donor in an electron transport chain. An electron transport chain is a process in which a series of electron carriers operate together to transfer electrons from donors to any of several different terminal electron acceptors to generate a transmembrane electrochemical gradient.
glyceraldehyde oxidoreductase activity Catalysis of the reaction: A + D-glyceraldehyde + H2O = (R)-glycerate + AH2 + H(+).
glycerol dehydrogenase [NADP+] activity Catalysis of the reaction: glycerol + NADP+ = D-glyceraldehyde + NADPH.
NADP-retinol dehydrogenase activity Catalysis of the reaction: all-trans-retinol + NADP+ = all-trans-retinal + NADPH + H+.
prostaglandin H2 endoperoxidase reductase activity Catalysis of the reaction: prostaglandin H2 + NADPH + H+ -> prostaglandin F2alpha + NADP+. This reaction is the reduction of prostaglandin H2 ((5Z,13E)-(15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoate) to prostaglandin F2alpha ((5Z,13E)-(15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dienoate).
retinal dehydrogenase activity Catalysis of the reaction: retinal + NAD+ + H2O = retinoate + NADH. Acts on both 11-trans and 13-cis forms of retinal.

12 GO annotations of biological process

Name Definition
C21-steroid hormone biosynthetic process The chemical reactions and pathways resulting in the formation of C21-steroid hormones, steroid compounds containing 21 carbons which function as hormones.
carbohydrate metabolic process The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
cellular hyperosmotic salinity response Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, an increase in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
daunorubicin metabolic process The chemical reactions and pathways involving daunorubicin, a chemotherapeutic of the anthracycline family that is given as a treatment for some types of cancer.
doxorubicin metabolic process The chemical reactions and pathways involving doxorubicin, an anthracycline antibiotic, used in cancer chemotherapy.
epithelial cell maturation The developmental process, independent of morphogenetic (shape) change, that is required for an epithelial cell to attain its fully functional state. An epithelial cell is a cell usually found in a two-dimensional sheet with a free surface.
fructose biosynthetic process The chemical reactions and pathways resulting in the formation of fructose, the ketohexose arabino-2-hexulose.
metanephric collecting duct development The process whose specific outcome is the progression of a collecting duct in the metanephros over time, from its formation to the mature structure. The collecting duct responds to vasopressin and aldosterone to regulate water, electrolyte and acid-base balance. The collecting duct is the final common path through which urine flows before entering the ureter and then emptying into the bladder.
negative regulation of apoptotic process Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
regulation of urine volume Any process that modulates the amount of urine excreted from the body over a unit of time.
renal water homeostasis Renal process involved in the maintenance of an internal steady state of water in the body.
retinoid metabolic process The chemical reactions and pathways involving retinoids, any member of a class of isoprenoids that contain or are derived from four prenyl groups linked head-to-tail. Retinoids include retinol and retinal and structurally similar natural derivatives or synthetic compounds, but need not have vitamin A activity.

10 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P16116 AKR1B1 Aldo-keto reductase family 1 member B1 Bos taurus (Bovine) PR
O60218 AKR1B10 Aldo-keto reductase family 1 member B10 Homo sapiens (Human) PR
P45377 Akr1b8 Aldose reductase-related protein 2 Mus musculus (Mouse) PR
P45376 Akr1b1 Aldo-keto reductase family 1 member B1 Mus musculus (Mouse) PR
P80276 AKR1B1 Aldo-keto reductase family 1 member B1 Sus scrofa (Pig) PR
P07943 Akr1b1 Aldo-keto reductase family 1 member B1 Rattus norvegicus (Rat) PR
Q84TF0 AKR4C10 Aldo-keto reductase family 4 member C10 Arabidopsis thaliana (Mouse-ear cress) PR
Q9M338 AKR4C11 Aldo-keto reductase family 4 member C11 Arabidopsis thaliana (Mouse-ear cress) PR
Q0PGJ6 AKR4C9 NADPH-dependent aldo-keto reductase, chloroplastic Arabidopsis thaliana (Mouse-ear cress) PR
O80944 AKR4C8 Aldo-keto reductase family 4 member C8 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MASRLLLNNG AKMPILGLGT WKSPPGQVTE AVKVAIDVGY RHIDCAHVYQ NENEVGVAIQ
70 80 90 100 110 120
EKLREQVVKR EELFIVSKLW CTYHEKGLVK GACQKTLSDL KLDYLDLYLI HWPTGFKPGK
130 140 150 160 170 180
EFFPLDESGN VVPSDTNILD TWAAMEELVD EGLVKAIGIS NFNHLQVEMI LNKPGLKYKP
190 200 210 220 230 240
AVNQIECHPY LTQEKLIQYC QSKGIVVTAY SPLGSPDRPW AKPEDPSLLE DPRIKAIAAK
250 260 270 280 290 300
HNKTTAQVLI RFPMQRNLVV IPKSVTPERI AENFKVFDFE LSSQDMTTLL SYNRNWRVCA
310
LLSCTSHKDY PFHEEF